ARGUS maintains a Hold rating on Celgene Corp. (Nasdaq: CELG), citing current valuation.

ARGUS analyst says, "The company is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE